PDB Short entry for 3QRI HEADER TRANSFERASE/TRANSFERASE INHIBITOR 18-FEB-11 3QRI TITLE THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DCC- TITLE 2 2036 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 229-499; COMPND 5 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1, PROTO- COMPND 6 ONCOGENE C-ABL, P150; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS ABL1, KINASE, KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.W.CHAN,S.C.WISE,M.D.KAUFMAN,Y.M.AHN,C.L.ENSINGER,T.HAACK,M.M.HOOD, AUTHOR 2 J.JONES,J.W.LORD,W.P.LU,D.MILLER,W.C.PATT,B.D.SMITH,P.A.PETILLO, AUTHOR 3 T.J.RUTKOSKI,H.TELIKEPALLI,L.VOGETI,T.YAO,L.CHUN,R.CLARK, AUTHOR 4 P.EVANGELISTA,L.C.GAVRILESCU,K.LAZARIDES,V.M.ZALESKAS,L.J.STEWART, AUTHOR 5 R.A.VAN ETTEN,D.L.FLYNN REVDAT 3 03-APR-24 3QRI 1 REMARK REVDAT 2 21-FEB-24 3QRI 1 REMARK SEQADV REVDAT 1 01-JUN-11 3QRI 0 JRNL AUTH W.W.CHAN,S.C.WISE,M.D.KAUFMAN,Y.M.AHN,C.L.ENSINGER,T.HAACK, JRNL AUTH 2 M.M.HOOD,J.JONES,J.W.LORD,W.P.LU,D.MILLER,W.C.PATT, JRNL AUTH 3 B.D.SMITH,P.A.PETILLO,T.J.RUTKOSKI,H.TELIKEPALLI,L.VOGETI, JRNL AUTH 4 T.YAO,L.CHUN,R.CLARK,P.EVANGELISTA,L.C.GAVRILESCU, JRNL AUTH 5 K.LAZARIDES,V.M.ZALESKAS,L.J.STEWART,R.A.VAN ETTEN,D.L.FLYNN JRNL TITL CONFORMATIONAL CONTROL INHIBITION OF THE BCR-ABL1 TYROSINE JRNL TITL 2 KINASE, INCLUDING THE GATEKEEPER T315I MUTANT, BY THE JRNL TITL 3 SWITCH-CONTROL INHIBITOR DCC-2036. JRNL REF CANCER CELL V. 19 556 2011 JRNL REFN ISSN 1535-6108 JRNL PMID 21481795 JRNL DOI 10.1016/J.CCR.2011.03.003 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0088 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 32074 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1540 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1695 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 77.48 REMARK 3 BIN R VALUE (WORKING SET) : 0.1970 REMARK 3 BIN FREE R VALUE SET COUNT : 98 REMARK 3 BIN FREE R VALUE : 0.3190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4329 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 400 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.32000 REMARK 3 B22 (A**2) : -1.00000 REMARK 3 B33 (A**2) : 0.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.85000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.240 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.194 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.114 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.914 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.871 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4591 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3090 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6242 ; 1.438 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7527 ; 0.857 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 554 ; 4.599 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 206 ;34.285 ;24.126 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 792 ;12.154 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;12.014 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 656 ; 0.077 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5057 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 926 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2706 ; 0.482 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1088 ; 0.067 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4371 ; 0.900 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1885 ; 1.087 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1861 ; 1.794 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 4 REMARK 4 3QRI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-FEB-11. REMARK 100 THE DEPOSITION ID IS D_1000064011. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.20 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL, SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31426 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 75.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: ABL KINASE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 32% PEG 3000, 100MM TRIS PH 8.2, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 290K, PH 8.20 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.85000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 59.70000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 223 REMARK 465 GLU A 499 REMARK 465 THR B 223 REMARK 465 SER B 224 REMARK 465 MET B 225 REMARK 465 ASP B 226 REMARK 465 PRO B 227 REMARK 465 SER B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 ASN B 231 REMARK 465 LYS B 274 REMARK 465 GLU B 275 REMARK 465 ASP B 276 REMARK 465 THR B 277 REMARK 465 MET B 278 REMARK 465 GLU B 499 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 238 CG CD OE1 OE2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 ASP A 276 CG OD1 OD2 REMARK 470 PHE A 497 CE1 CE2 CZ REMARK 470 TYR B 232 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP B 233 CG OD1 OD2 REMARK 470 GLU B 238 CG CD OE1 OE2 REMARK 470 ARG B 307 CD NE CZ NH1 NH2 REMARK 470 GLU B 308 CG CD OE1 OE2 REMARK 470 PHE B 359 CE1 CE2 CZ REMARK 470 GLN B 447 CG CD OE1 NE2 REMARK 470 LYS B 467 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 245 -143.90 -92.40 REMARK 500 GLU A 275 -162.46 -165.60 REMARK 500 ARG A 362 -16.08 84.86 REMARK 500 ASP A 363 49.45 -147.95 REMARK 500 ASP A 391 42.20 -102.87 REMARK 500 PRO A 441 114.89 -39.60 REMARK 500 SER A 446 1.88 -65.62 REMARK 500 ASP A 455 13.44 82.71 REMARK 500 LYS B 245 -162.74 -125.30 REMARK 500 ARG B 362 -17.97 85.01 REMARK 500 ASP B 363 44.71 -148.11 REMARK 500 ASP B 391 -31.72 94.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 919 A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 919 B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3QRJ RELATED DB: PDB REMARK 900 HUMAN ABL2 KINASE DOMAIN T315I MUTANT IN COMPLEX WITH DCC-2036 REMARK 900 RELATED ID: 3QRK RELATED DB: PDB REMARK 900 HUMAN ABL2 KINASE DOMAIN IN COMPLEX WITH DP-987 DBREF 3QRI A 229 499 UNP P00519 ABL1_HUMAN 229 499 DBREF 3QRI B 229 499 UNP P00519 ABL1_HUMAN 229 499 SEQADV 3QRI THR A 223 UNP P00519 EXPRESSION TAG SEQADV 3QRI SER A 224 UNP P00519 EXPRESSION TAG SEQADV 3QRI MET A 225 UNP P00519 EXPRESSION TAG SEQADV 3QRI ASP A 226 UNP P00519 EXPRESSION TAG SEQADV 3QRI PRO A 227 UNP P00519 EXPRESSION TAG SEQADV 3QRI SER A 228 UNP P00519 EXPRESSION TAG SEQADV 3QRI THR B 223 UNP P00519 EXPRESSION TAG SEQADV 3QRI SER B 224 UNP P00519 EXPRESSION TAG SEQADV 3QRI MET B 225 UNP P00519 EXPRESSION TAG SEQADV 3QRI ASP B 226 UNP P00519 EXPRESSION TAG SEQADV 3QRI PRO B 227 UNP P00519 EXPRESSION TAG SEQADV 3QRI SER B 228 UNP P00519 EXPRESSION TAG SEQRES 1 A 277 THR SER MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 A 277 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 A 277 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 A 277 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 A 277 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 A 277 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 A 277 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 A 277 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 A 277 LEU ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL SEQRES 10 A 277 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 A 277 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 A 277 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 A 277 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 A 277 THR TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 A 277 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 A 277 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 A 277 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 A 277 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 A 277 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 A 277 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 A 277 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 A 277 MET PHE GLN GLU SEQRES 1 B 277 THR SER MET ASP PRO SER SER PRO ASN TYR ASP LYS TRP SEQRES 2 B 277 GLU MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU SEQRES 3 B 277 GLY GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP SEQRES 4 B 277 LYS LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS SEQRES 5 B 277 GLU ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA SEQRES 6 B 277 ALA VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN SEQRES 7 B 277 LEU LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE SEQRES 8 B 277 ILE THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR SEQRES 9 B 277 LEU ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL SEQRES 10 B 277 LEU LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU SEQRES 11 B 277 TYR LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA SEQRES 12 B 277 ALA ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS SEQRES 13 B 277 VAL ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP SEQRES 14 B 277 THR TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS SEQRES 15 B 277 TRP THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER SEQRES 16 B 277 ILE LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP SEQRES 17 B 277 GLU ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE SEQRES 18 B 277 ASP LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR SEQRES 19 B 277 ARG MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR SEQRES 20 B 277 GLU LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP SEQRES 21 B 277 ARG PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR SEQRES 22 B 277 MET PHE GLN GLU HET NA A 1 1 HET NA A 2 1 HET 919 A 500 41 HET 919 B 2 41 HETNAM NA SODIUM ION HETNAM 919 4-[4-({[3-TERT-BUTYL-1-(QUINOLIN-6-YL)-1H-PYRAZOL-5- HETNAM 2 919 YL]CARBAMOYL}AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE- HETNAM 3 919 2-CARBOXAMIDE HETSYN 919 DCC-2036 FORMUL 3 NA 2(NA 1+) FORMUL 5 919 2(C30 H28 F N7 O3) FORMUL 7 HOH *400(H2 O) HELIX 1 1 GLU A 238 THR A 240 5 3 HELIX 2 2 GLY A 249 GLN A 252 5 4 HELIX 3 3 LYS A 263 SER A 265 5 3 HELIX 4 4 GLU A 279 ILE A 293 1 15 HELIX 5 5 ASN A 322 CYS A 330 1 9 HELIX 6 6 ASN A 336 LYS A 357 1 22 HELIX 7 7 ALA A 365 ARG A 367 5 3 HELIX 8 8 GLU A 373 HIS A 375 5 3 HELIX 9 9 GLY A 383 LEU A 387 5 5 HELIX 10 10 LYS A 404 THR A 406 5 3 HELIX 11 11 ALA A 407 ASN A 414 1 8 HELIX 12 12 SER A 417 THR A 434 1 18 HELIX 13 13 ASP A 444 SER A 446 5 3 HELIX 14 14 GLN A 447 LYS A 454 1 8 HELIX 15 15 PRO A 465 TRP A 476 1 12 HELIX 16 16 ASN A 479 ARG A 483 5 5 HELIX 17 17 SER A 485 THR A 495 1 11 HELIX 18 18 GLU B 238 THR B 240 5 3 HELIX 19 19 GLY B 249 GLN B 252 5 4 HELIX 20 20 LYS B 263 SER B 265 5 3 HELIX 21 21 GLU B 279 ILE B 293 1 15 HELIX 22 22 ASN B 322 CYS B 330 1 9 HELIX 23 23 ASN B 336 LYS B 357 1 22 HELIX 24 24 ALA B 365 ARG B 367 5 3 HELIX 25 25 GLU B 373 HIS B 375 5 3 HELIX 26 26 GLY B 383 LEU B 387 5 5 HELIX 27 27 PRO B 402 THR B 406 5 5 HELIX 28 28 ALA B 407 ASN B 414 1 8 HELIX 29 29 SER B 417 THR B 434 1 18 HELIX 30 30 GLN B 447 LYS B 454 1 8 HELIX 31 31 PRO B 465 TRP B 476 1 12 HELIX 32 32 ASN B 479 ARG B 483 5 5 HELIX 33 33 SER B 485 THR B 495 1 11 SHEET 1 A 5 ILE A 242 LYS A 247 0 SHEET 2 A 5 VAL A 256 TRP A 261 -1 O GLU A 258 N LYS A 245 SHEET 3 A 5 LEU A 266 LEU A 273 -1 O LEU A 266 N TRP A 261 SHEET 4 A 5 PHE A 311 GLU A 316 -1 O ILE A 313 N LYS A 271 SHEET 5 A 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 B 2 CYS A 369 VAL A 371 0 SHEET 2 B 2 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 C 2 TYR A 393 HIS A 396 0 SHEET 2 C 2 ALA A 399 PRO A 402 -1 O ALA A 399 N HIS A 396 SHEET 1 D 5 ILE B 242 LYS B 247 0 SHEET 2 D 5 VAL B 256 TRP B 261 -1 O GLU B 258 N LYS B 245 SHEET 3 D 5 LEU B 266 THR B 272 -1 O LEU B 266 N TRP B 261 SHEET 4 D 5 TYR B 312 GLU B 316 -1 O THR B 315 N ALA B 269 SHEET 5 D 5 LEU B 301 CYS B 305 -1 N LEU B 302 O ILE B 314 SHEET 1 E 2 CYS B 369 VAL B 371 0 SHEET 2 E 2 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 F 2 THR B 394 HIS B 396 0 SHEET 2 F 2 ALA B 399 PHE B 401 -1 O PHE B 401 N THR B 394 CISPEP 1 PRO A 309 PRO A 310 0 -2.81 CISPEP 2 PHE A 497 GLN A 498 0 1.19 CISPEP 3 PRO B 309 PRO B 310 0 0.34 CISPEP 4 GLY B 390 ASP B 391 0 3.92 SITE 1 AC1 19 HOH A 41 HOH A 53 LEU A 248 VAL A 256 SITE 2 AC1 19 ALA A 269 LYS A 271 GLU A 286 MET A 290 SITE 3 AC1 19 VAL A 299 ILE A 313 THR A 315 GLU A 316 SITE 4 AC1 19 PHE A 317 MET A 318 PHE A 359 HIS A 361 SITE 5 AC1 19 ALA A 380 ASP A 381 PHE A 382 SITE 1 AC2 15 LEU B 248 VAL B 256 ALA B 269 LYS B 271 SITE 2 AC2 15 GLU B 286 MET B 290 VAL B 299 THR B 315 SITE 3 AC2 15 GLU B 316 MET B 318 LEU B 370 ALA B 380 SITE 4 AC2 15 ASP B 381 PHE B 382 HOH B 570 CRYST1 60.260 59.700 79.430 90.00 108.71 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016595 0.000000 0.005620 0.00000 SCALE2 0.000000 0.016750 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013292 0.00000